Sorry, you need to enable JavaScript to visit this website.

Plant-derived natural compounds in genetic vaccination and therapy for HPV-associated cancers

TitlePlant-derived natural compounds in genetic vaccination and therapy for HPV-associated cancers
Publication TypeArticolo su Rivista peer-reviewed
Year of Publication2020
AuthorsFranconi, Rosella, Massa Silvia, Paolini F., Vici P., and Venuti A.

Antigen-specific immunotherapy and, in particular, DNA vaccination provides an established approach for tackling human papillomavirus (HPV) cancers at different stages. DNA vaccines are stable and have a cost-effective production. Their intrinsic low immunogenicity has been improved by several strategies with some success, including fusion of HPV antigens with plant gene sequences. Another approach for the control of HPV cancers is the use of natural immunomodulatory agents like those derived from plants, that are able to interfere in carcinogenesis by modulating many different cellular pathways and, in some instances, to reduce chemo- and radiotherapy resistance of tumors. Indeed, plant-derived compounds represent, in many cases, an abundantly available, cost-effective source of molecules that can be either harvested directly in nature or obtained from plant cell cultures. In this review, an overview of the most relevant data reported in literature on the use of plant natural compounds and genetic vaccines that include plant-derived sequences against HPV tumors is provided. The purpose is also to highlight the still under-explored potential of multimodal treatments implying DNA vaccination along with plant-derived agents. © 2020 by the authors.


cited By 0

Citation KeyFranconi20201